Skip to main content
Clinical Trials/IRCT138705301058N1
IRCT138705301058N1
Recruiting
N/A

Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study (Phase II)

research institute for endocrine sciences0 sites15,005 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
ifestyle modification interventions in preventing or postponing the development of NCD risk factors and outcomes with special focus on angina pectoris, myocardial infarction, cerebrovascular events, diabetes mellitus, hypertension and dyslipidemia..
Sponsor
research institute for endocrine sciences
Enrollment
15005
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
research institute for endocrine sciences

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 3 years and over who were residence of the District 13 of Tehran and were under the coverage of three medical health centers of Salavati, Mohammadian, and Lailatolghadr, were selected using multistage cluster random sampling method. All members of each family not mentally disabled, including those having or not having risk factors, were interviewed.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials